INDRAMEDCO For Swing Trading
Updated
INDRAMEDCO Prediction for Swing/ Positional Trading
Entry 1 was at 175. Entry 2 was at 192. You can enter into trade above 218 or CMP or you can entry according to your experience.
Sls- according to you RRR.
Targets- 230,242,255,270,285,…(more will be updated later if need )
According to your “STOMACH” book your profit. Always maintain your risk management.
Watch Carefully – The Chart Explains For Itself.
Disclaimer:
I am not a SEBI Registered Analyst. Anything posted here is my own analysis and views. This is created for educational purposes only. Always consult your Financial Advisor before taking any decision or trade.
Happy trading.
About INDRAMEDCO –
Indraprastha Medical Corp. Ltd. engages in the healthcare business. It operates through the following segments: Healthcare Deliveries, Pharma, and Medical Technologies and Others. The company was founded on March 16, 1988 and is headquartered in New Delhi, India.
Entry 1 was at 175. Entry 2 was at 192. You can enter into trade above 218 or CMP or you can entry according to your experience.
Sls- according to you RRR.
Targets- 230,242,255,270,285,…(more will be updated later if need )
According to your “STOMACH” book your profit. Always maintain your risk management.
Watch Carefully – The Chart Explains For Itself.
Disclaimer:
I am not a SEBI Registered Analyst. Anything posted here is my own analysis and views. This is created for educational purposes only. Always consult your Financial Advisor before taking any decision or trade.
Happy trading.
About INDRAMEDCO –
Indraprastha Medical Corp. Ltd. engages in the healthcare business. It operates through the following segments: Healthcare Deliveries, Pharma, and Medical Technologies and Others. The company was founded on March 16, 1988 and is headquartered in New Delhi, India.
Note
Target 1 (230) achieved Note
218 to 280
For Paid Course- suraranjantradinglevels@gmail.com
No Call Telegram- t.me/suraranjantradinglevels
No Call Telegram- t.me/suraranjantradinglevels
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.